NASDAQ:SNWV - Nasdaq - US80303D3052 - Common Stock - Currency: USD
30.6
-0.36 (-1.16%)
The current stock price of SNWV is 30.6 USD. In the past month the price increased by 1.39%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABT | ABBOTT LABORATORIES | 27.84 | 230.77B | ||
ISRG | INTUITIVE SURGICAL INC | 69.43 | 190.13B | ||
BSX | BOSTON SCIENTIFIC CORP | 38.56 | 154.00B | ||
SYK | STRYKER CORP | 30.13 | 144.10B | ||
MDT | MEDTRONIC PLC | 15.42 | 105.58B | ||
BDX | BECTON DICKINSON AND CO | 11.72 | 47.42B | ||
EW | EDWARDS LIFESCIENCES CORP | 28.82 | 44.05B | ||
IDXX | IDEXX LABORATORIES INC | 41.55 | 38.39B | ||
RMD | RESMED INC | 26.65 | 35.48B | ||
DXCM | DEXCOM INC | 49.41 | 31.97B | ||
GEHC | GE HEALTHCARE TECHNOLOGY | 14.58 | 30.72B | ||
PHG | KONINKLIJKE PHILIPS NVR- NY | 15.34 | 22.64B |
SANUWAVE Health, Inc. is a shockwave technology company, which engages in the development and commercialization of patented noninvasive, biological response activating devices. The company is headquartered in Eden Prairie, Minnesota and currently employs 46 full-time employees. The company went IPO on 2008-11-07. The company is a provider of wound care products. The company is focused on the research, development, and commercialization of its patented, non-invasive, and biological response-activating medical systems for the repair and regeneration of skin, musculoskeletal tissue, and vascular structures. The company applies and researches its patented energy transfer technologies in wound healing, orthopedic/spine, and aesthetic/cosmetic. Its two primary systems are UltraMIST and PACE. The UltraMIST system provides, through a fluid mist, low-frequency, non-contact, and pain free ultrasound energy deep inside the wound bed that promotes healing. The PACE systems use acoustic pressure shockwaves generated by the Company's Pulsed Acoustic Cellular Expression technology to converge at precise selected targets to produce short duration compression burst and are used in both wound and orthopedic applications under the brand names dermaPACE and others.
SANUWAVE HEALTH INC
11495 Valley View Road
Eden Prairie MINNESOTA US
Employees: 31
Phone: 18005458810
The current stock price of SNWV is 30.6 USD. The price decreased by -1.16% in the last trading session.
The exchange symbol of SANUWAVE HEALTH INC is SNWV and it is listed on the Nasdaq exchange.
SNWV stock is listed on the Nasdaq exchange.
SANUWAVE HEALTH INC (SNWV) has a market capitalization of 261.63M USD. This makes SNWV a Micro Cap stock.
SANUWAVE HEALTH INC (SNWV) currently has 31 employees.
SANUWAVE HEALTH INC (SNWV) has a support level at 29.26 and a resistance level at 30.9. Check the full technical report for a detailed analysis of SNWV support and resistance levels.
The Revenue of SANUWAVE HEALTH INC (SNWV) is expected to grow by 228.83% in the next year. Check the estimates tab for more information on the SNWV EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
SNWV does not pay a dividend.
SANUWAVE HEALTH INC (SNWV) will report earnings on 2025-08-11.
SANUWAVE HEALTH INC (SNWV) does not have a PE ratio as the earnings reported over the last twelve months were negative (-18.75).
The outstanding short interest for SANUWAVE HEALTH INC (SNWV) is 0.25% of its float. Check the ownership tab for more information on the SNWV short interest.
ChartMill assigns a technical rating of 4 / 10 to SNWV.
ChartMill assigns a fundamental rating of 2 / 10 to SNWV. Both the profitability and financial health of SNWV have multiple concerns.
Over the last trailing twelve months SNWV reported a non-GAAP Earnings per Share(EPS) of -18.75. The EPS increased by 34.19% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -1.78% | ||
ROE | N/A | ||
Debt/Equity | N/A |
ChartMill assigns a Buy % Consensus number of 83% to SNWV. The Buy consensus is the average rating of analysts ratings from 7 analysts.
For the next year, analysts expect an EPS growth of -2% and a revenue growth 228.83% for SNWV